Moderna is a company that you have been hearing about a lot this year and back in 2021 and 2020 as well. It’s been making headlines a lot in relation to the covid vaccines and the trend continues in 2022 as well.
Check out the latest reports involving Moderna vaccines below.
It seems that the very rare side effect among under-31s of the Moderna coronavirus vaccine leads to the fact that Belgium stopped using this vaccine last month for the first two vaccine doses of people in this age group. We suggest that you check out the previous article that we shared in order to learn more available details.
Also, Moderna has been working on some new treatments for heart-related problems, and this is yet another interesting article you should check out.
Moderna works on covid booster
Reuters press agency noted that there is an Omicron-specific booster that could be ready by August, the CEO of U.S. biotech firm Moderna told Reuters.
It’s important to note that the company is still gathering clinical data to determine whether that vaccine would offer better protection than a new dose of the existing vaccine.
“Last month Moderna began clinical trials for a booster dose specifically designed to target Omicron but initial results from studies in monkeys show the Omicron-specific shot may not offer stronger protection than a new dose of the existing vaccine.”
Moderna chief executive Stephane Bancel said the following:
“We believe a booster will be needed. I don’t know yet if it is going to be the existing vaccine, Omicron-only, or bivalent: Omicron and existing vaccine, two mRNA in one dose.”
Stay tuned for more news, and also stay safe.